Jianqi Wu

530 total citations · 1 hit paper
18 papers, 380 citations indexed

About

Jianqi Wu is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Jianqi Wu has authored 18 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Jianqi Wu's work include Respiratory viral infections research (5 papers), Immune Cell Function and Interaction (5 papers) and IL-33, ST2, and ILC Pathways (3 papers). Jianqi Wu is often cited by papers focused on Respiratory viral infections research (5 papers), Immune Cell Function and Interaction (5 papers) and IL-33, ST2, and ILC Pathways (3 papers). Jianqi Wu collaborates with scholars based in China, Japan and United States. Jianqi Wu's co-authors include Anhua Wu, Peng Cheng, Beixing Liu, Gefei Guan, Shuai Shen, Ling Chen, Chen Zhu, Tianqi Liu, Cunyi Zou and Sheng Zeng and has published in prestigious journals such as Cancer Research, Oncogene and Theranostics.

In The Last Decade

Jianqi Wu

17 papers receiving 375 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance

2022 153 citations Tianqi Liu, Chen Zhu et al. Neuro-Oncology profile →

Peers

Jianqi Wu

PRM

IMMUN

ONCOL

Nicholas A. Zorko United States

Yuanlin Wu China

Mordehay Klepfish Israel

Amirtharaj Francis India

Jaroslav Žák United States

Daniel F. Camacho United States

Chun Xia Liu China

Weimin Ding China

Megan Karwan United States

Juan Gu China

Nicholas A. Zorko United States

Jianqi Wu

104 ×0.6

95 ×0.7

PRM

176 ×1.2

IMMUN

39 ×0.4

165 ×2.8

ONCOL

Citations per year, relative to Jianqi Wu Jianqi Wu (= 1×) peers Nicholas A. Zorko

Countries citing papers authored by Jianqi Wu

Since Specialization

Citations

This map shows the geographic impact of Jianqi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqi Wu more than expected).

Fields of papers citing papers by Jianqi Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianqi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqi Wu. The network helps show where Jianqi Wu may publish in the future.

Co-authorship network of co-authors of Jianqi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianqi Wu. A scholar is included among the top collaborators of Jianqi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianqi Wu. Jianqi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wu, Jianqi, et al.. (2025). Targeting ARPC1B Overcomes Immune Checkpoint Inhibitor Resistance in Glioblastoma by Reversing Protumorigenic Macrophage Polarization. Cancer Research. 85(7). 1236–1252. 4 indexed citations

Liu, Jiewei, et al.. (2025). Disseminated Talaromyces marneffei infection mimicking tuberculosis in an HIV-negative adult with anti–IFN-γ autoantibodies: a case report. BMC Infectious Diseases. 26(1). 1–1.

Zhou, Mengnan, Jianqi Wu, Yang Shao, et al.. (2024). Short-chain fatty acids reverses gut microbiota dysbiosis-promoted progression of glioblastoma by up-regulating M1 polarization in the tumor microenvironment. International Immunopharmacology. 141. 112881–112881. 15 indexed citations

Ren, Xiufang, Wei Gao, Jianqi Wu, et al.. (2024). The biological behavior and clinical outcome of pituitary adenoma are affected by the microenvironment. CNS Neuroscience & Therapeutics. 30(5). e14729–e14729. 3 indexed citations

Liu, Xing, Qing Guo, Jianqi Wu, et al.. (2023). Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate. Communications Biology. 6(1). 1281–1281. 2 indexed citations

Wu, Jianqi, Shuai Shen, Tianqi Liu, et al.. (2022). Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner. Oncogene. 41(21). 3024–3036. 21 indexed citations

Chen, Xin, Tianqi Liu, Jianqi Wu, et al.. (2022). Molecular profiling identifies distinct subtypes across TP53 mutant tumors. JCI Insight. 7(23). 8 indexed citations

Liu, Tianqi, Chen Zhu, Xin Chen, et al.. (2022). Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neuro-Oncology. 24(7). 1113–1125. 153 indexed citations breakdown →

Wu, Jianqi, Xin Zhao, Shuai Shen, et al.. (2021). Establishment of tumor inflammasome clusters with distinct immunogenomic landscape aids immunotherapy. Theranostics. 11(20). 9884–9903. 15 indexed citations

10.

Shen, Shuai, Zihao Yan, Jianqi Wu, et al.. (2020). Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy. Frontiers in Oncology. 10. 581197–581197. 12 indexed citations

11.

Guan, Gefei, Xue Li, Jianqi Wu, et al.. (2020). Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma. Journal of Translational Medicine. 18(1). 378–378. 25 indexed citations

12.

Wu, Jianqi, et al.. (2019). Critical role of OX40/OX40L in ILC2-mediated activation of CD4+T cells during respiratory syncytial virus infection in mice. International Immunopharmacology. 76. 105784–105784. 21 indexed citations

13.

Wu, Jianqi, et al.. (2017). Natural helper cells are associated with the exacerbated airway inflammation seen during RSV reinfection of neonatally primed mice. International Immunopharmacology. 45. 156–162. 1 indexed citations

14.

Wu, Jianqi, Lei Xu, Xu Han, et al.. (2017). Role of γδ T cells in exacerbated airway inflammation during reinfection of neonatally primed mice in adulthood. Journal of Medical Virology. 89(12). 2108–2115. 3 indexed citations

15.

Liu, Jing, Jianqi Wu, Feifei Qi, et al.. (2015). Natural helper cells contribute to pulmonary eosinophilia by producing IL-13 via IL-33/ST2 pathway in a murine model of respiratory syncytial virus infection. International Immunopharmacology. 28(1). 337–343. 30 indexed citations

16.

Zeng, Sheng, Jianqi Wu, Jing Liu, et al.. (2014). Infection with respiratory syncytial virus influences FasL-mediated apoptosis of pulmonary γδ T cells in a murine model of allergen sensitization. Journal of Asthma. 51(4). 360–365. 4 indexed citations

17.

Liu, Jing, Jianqi Wu, Bing Wang, et al.. (2013). Oral vaccination with a liposome‐encapsulated influenza DNA vaccine protects mice against respiratory challenge infection. Journal of Medical Virology. 86(5). 886–894. 52 indexed citations

18.

Zhang, Leiying, Jing Liu, En‐Hua Wang, et al.. (2012). Respiratory syncytial virus protects against the subsequent development of ovalbumin‐induced allergic responses by inhibiting Th2‐type γδ T cells. Journal of Medical Virology. 85(1). 149–156. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact